Marilena Steiger

Dr. Marilena Steiger is a Research Fellow at the Institute of Pharmaceutical Sciences (IPW) at ETH Zürich, affiliated with the Professorship for Drug Formulation and Delivery. Her research focuses on advanced drug delivery systems, particularly lipid nanocapsules for treating ocular diseases such as retinopathy of prematurity. She holds a patent for a nanoparticle-based treatment for ocular diseases and has received awards including the 2022 Innovation Prize from Biopark Regensburg GmbH and a poster prize from the 2020 European and Global CLINAM-Summit.

Her work integrates nanotechnology and pharmaceutical sciences to develop novel therapeutic delivery platforms, with applications in both diagnostics (via dual-detectable nanoparticles) and targeted treatments for retinal disorders. Key collaborations involve Professor Achim Goepferich, and her research emphasizes translational medicine with potential clinical impact.

Dr. Steiger’s publications span high-impact journals like Science Advances and Drug Discovery Today, reflecting her contributions to nanomedicine and drug formulation. She actively engages in patent development and academic-industry partnerships to advance biomedical innovations.